Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.
Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, Witjes JA, Todenhöfer T, Hakenberg OW, Grimm MO, Goebell PJ, Burger M, Jensen JB, Schmitz-Dräger BJ.
Benderska-Söder N, et al. Among authors: goebell pj.
Urol Oncol. 2024 Aug;42(8):229-235. doi: 10.1016/j.urolonc.2024.01.025. Epub 2024 Feb 24.
Urol Oncol. 2024.
PMID: 38403529
Review.